| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.062 | 0.06 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.06 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.06 | 0.06 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.062 | 0.06 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.068 | 0.07 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.059 | 0.07 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.07 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.061 | 0.07 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.07 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.07 |